Disruptive Innovations to Advance Clinical Trials Conference Confirms Program Line-up for September 7-8, 2017

DPharm US

“DPharm has grown to offer the widest range of new ideas and how to bootstrap them to advance next generation clinical research,” says Valerie Bowling.

The Conference Forum has announced the program line-up for the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials event, which will take place on September 7-8, 2017 in Boston, MA.

Co-chairs Andreas Koester, MD, PhD, VP, Innovation, R&D Operations, Janssen, Craig Lipset, MBA, Head of Clinical Innovation, Pfizer, Inc and Bray Patrick-Lake, MFS, Director of Stakeholder Engagement, Duke Clinical Research Institute, together host over 70 speakers who challenge conventional thinking and inspire new ideas in clinical trials for 21st century drug development.

“Since developing the first industry forum six years ago on how to think radically differently about how to perform clinical research, DPharm has grown to offer the widest range of new ideas and how to bootstrap them to advance next generation clinical research,” says Valerie Bowling, conference director.

Part I of this year’s event focuses on “Patients, Innovation and Disruption” and kicks off with Patient Keynote Speaker Jessica Melore, who shares her harrowing, but inspirational story which reminds the R&D industry why we are disrupting innovation. R&D executives from Bayer, Pfizer and Allergan discuss what they want to disrupt, while Eli Lilly and Pfizer talk about bootstraping innovation. A presentation on ADAPTABLE, a new system to do clinical trials, shows how patients are actively engaged in the design, conduct, oversight and dissemination of the study. And speakers from Merck and Novartis aim to bust the myth of not being able to select the right sites for the right trials.

Part II deals with “New Ideas and Progress” that are being led by some surprising parties. Patient Disrupters: The Ultimate Partner showcases how patients and providers are working together to drive research, with speakers from OpenAPS, Mayo Clinic and Life-Saving Therapies Network. A case study on Turbo Tax for clinical trials is presented by goBalto and Allergan. Two tracks are available to hear from either companies with a progress report on the innovation they previously presented at…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *